DPM

Paragon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline™ Tape

Retrieved on: 
Friday, January 5, 2024

Paragon 28, Inc. (NYSE: FNA), is thrilled to announce the launch of the Grappler® Knotless Anchor System and Bridgeline™ Tape, enhancing the Company’s position in the fast-growing foot and ankle specific soft tissue market in 2024 and beyond.

Key Points: 
  • Paragon 28, Inc. (NYSE: FNA), is thrilled to announce the launch of the Grappler® Knotless Anchor System and Bridgeline™ Tape, enhancing the Company’s position in the fast-growing foot and ankle specific soft tissue market in 2024 and beyond.
  • Both the Grappler® Knotless Anchor System and Bridgeline™ Tape are highly complementary to a broad range of Paragon 28’s existing hardware products with several applications spanning multiple foot and ankle indications.
  • Surgeon designer, Mark Prissel, DPM commented, “The Grappler® Suture Anchor System is a comprehensive soft tissue anchoring product line that includes implants designed by and for foot and ankle surgeons for acute and chronic repairs.
  • With this comprehensive portfolio, Paragon 28® provides its customers with a single source to address their foot and ankle soft tissue needs.

Osino Announces Closing of Bridge Private Placement of Common Shares

Retrieved on: 
Friday, December 22, 2023

VANCOUVER, British Columbia, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Osino Resources Corp. (TSXV:OSI) (NSX:OSN) (FSE:RSR1) (OTCQX:OSIIF) ("Osino" or the "Company") is pleased to announce that it has completed the initial tranche of its previously announced non-brokered private placement (the "Offering") of common shares of the Company (the "Common Shares") to Dundee Precious Metals Inc. ("DPM").

Key Points: 
  • VANCOUVER, British Columbia, Dec. 22, 2023 (GLOBE NEWSWIRE) -- Osino Resources Corp. (TSXV:OSI) (NSX:OSN) (FSE:RSR1) (OTCQX:OSIIF) ("Osino" or the "Company") is pleased to announce that it has completed the initial tranche of its previously announced non-brokered private placement (the "Offering") of common shares of the Company (the "Common Shares") to Dundee Precious Metals Inc. ("DPM").
  • The Company issued 4,424,779 Common Shares to DPM at a price of C$1.13 per Common Share for aggregate gross proceeds to the Company of C$5,000,000.27.
  • After giving effect to the initial tranche of the Offering, DPM holds an aggregate of 8,235,379 Common Shares, representing approximately 4.9% of the Common Shares issued and outstanding on the date hereof, on a non-diluted basis.
  • The Common Shares were offered by way of private placement pursuant to applicable exemptions from prospectus requirements in British Columbia and Ontario.

Dundee Precious Metals Announces Acquisition of Osino

Retrieved on: 
Monday, December 18, 2023

Upon completion of the Transaction, DPM will issue 13,766,364 shares to Osino shareholders and existing Osino shareholders will own approximately 7% of the combined company.

Key Points: 
  • Upon completion of the Transaction, DPM will issue 13,766,364 shares to Osino shareholders and existing Osino shareholders will own approximately 7% of the combined company.
  • David Rae, President and Chief Executive Officer of Dundee Precious Metals, made the following comments in relation to the Osino acquisition:
    “Twin Hills represents a unique opportunity to add a high-quality development asset in an excellent mining jurisdiction to our portfolio.
  • The Board of Directors of Osino (the “Osino Board”) appointed a special committee of independent directors (the “Special Committee”) to consider and make a recommendation to the Osino Board with respect to the Transaction.
  • Accordingly, the Osino Board and the Special Committee recommend that Osino shareholders vote in favour of the Transaction.

Dundee Precious Metals Announces High-Grade Underground Maiden Mineral Resource Estimate of 1.8 Million Inferred Gold Ounces at its Čoka Rakita Project in Serbia

Retrieved on: 
Monday, December 11, 2023

TORONTO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) is pleased to announce a maiden Mineral Resource Estimate of 1.78 million ounces for its 100% owned Čoka Rakita gold project in eastern Serbia, where DPM announced a high-grade discovery in January 2023.

Key Points: 
  • TORONTO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) is pleased to announce a maiden Mineral Resource Estimate of 1.78 million ounces for its 100% owned Čoka Rakita gold project in eastern Serbia, where DPM announced a high-grade discovery in January 2023.
  • Strong maiden Mineral Resource estimate: Inferred Mineral Resource estimate (“MRE”) of 9.79 million tonnes (“Mt”) at a grade of 5.67 grams per tonne (“g/t”) for 1.78 million ounces of gold.
  • “The initial Mineral Resource estimate marks a significant milestone for DPM’s future growth and confirms Čoka Rakita’s potential as an attractive, high-quality gold project,” said David Rae, President and Chief Executive Officer of Dundee Precious Metals.
  • Material within the reporting MSO constraints (smoothed) was classified as Inferred Mineral Resources according to Mineral Resource confidence categories defined in the CIM Definition Standards for Mineral Resources and Mineral Reserves.

Voom Medical Devices Redefines Patient Engagement with Launch of Cutting-Edge Website and Doctor Locator for Bunionplasty® Procedure

Retrieved on: 
Thursday, December 21, 2023

Voom™ Medical Devices, Inc. ("Voom"), a trailblazing orthopedic medical device company and pioneer in minimally invasive bunion surgery (MIBS) solutions, proudly announces the debut of www.Bunionplasty.com .

Key Points: 
  • Voom™ Medical Devices, Inc. ("Voom"), a trailblazing orthopedic medical device company and pioneer in minimally invasive bunion surgery (MIBS) solutions, proudly announces the debut of www.Bunionplasty.com .
  • This groundbreaking website features an unprecedented searchable gallery showcasing before-and-after photographs of real patient bunion repairs, coupled with an innovative doctor locator tool.
  • The website also offers captivating bunion reveals through transformational videos showcasing key recovery milestones after the Bunionplasty® procedure.
  • For comprehensive information about Voom Medical Devices and its revolutionary No-Fusion Bunion Solution™ and other innovations, please visit www.voomdevices.com or contact [email protected] .

OSSIO’s Groundbreaking Option for Fixing Bone Fractures In Children Receives FDA Clearance

Retrieved on: 
Wednesday, December 6, 2023

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231206064383/en/
    The FDA has cleared the company’s OSSIOfiber® bio-integrative fixation technology for use in orthopedic surgery for children and adolescents needing bone fractures fixed, osteotomies, or fusions.
  • As a result, OSSIOfiber Compression Screws and Trimmable Fixation Nails may now be used in children from age two to 21 years in standard clinical practice.
  • Designed for rapid bone in-growth, regeneration and replacement, OSSIOfiber Intelligent Bone Regeneration Technology is a first-of-its-kind implant material stronger than cortical bone.
  • It can address many surgical applications through the manufacturing of endless implant designs, including nails, screws, staples, anchors and plates.

Dr. William M. Scholl College of Podiatric Medicine at Rosalind Franklin University Announces Historic $1 Million Matching-Fund Scholarship Challenge

Retrieved on: 
Wednesday, December 13, 2023

NORTH CHICAGO, Ill., Dec. 13, 2023 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science (RFU) announces a historic $1 million matching gift commitment for the Dr. William M. Scholl College of Podiatric Medicine .

Key Points: 
  • NORTH CHICAGO, Ill., Dec. 13, 2023 /PRNewswire/ -- Rosalind Franklin University of Medicine and Science (RFU) announces a historic $1 million matching gift commitment for the Dr. William M. Scholl College of Podiatric Medicine .
  • Historic $1 million matching gift commitment for the Dr. William M. Scholl College of Podiatric Medicine.
  • The extraordinary $1 million Scholl Matching Gift Challenge comes from an anonymous Scholl College alum and their spouse, generously committing to match all gifts toward the college dollar-for-dollar.
  • Matching funds will grow an endowed scholarship to provide four-year, need-based scholarships for Scholl College students in perpetuity.

OCM™ Wound Platform Demonstrates Antibacterial Activity in Porcine Wound Model, Significantly Reducing Methicillin-Resistant Staphylococcus Aureus (MRSA) and Pseudomonas Aeruginosa (PA) Compared to Comparator and Control Groups

Retrieved on: 
Friday, December 8, 2023

"Limiting bacterial growth is a critical therapeutic aim in treating advanced wounds, but complicating factors often prevent success.

Key Points: 
  • "Limiting bacterial growth is a critical therapeutic aim in treating advanced wounds, but complicating factors often prevent success.
  • The current study was designed to evaluate the antimicrobial and wound-healing effects of OCM™ and Omeza® Skin Protectant against a comparator and a control in a porcine wound model.
  • Wounds in all groups were debrided, treated (except negative control), covered with polyurethane dressings, and retreated on days 4 and 8.
  • OCM™ alone and OCM™ plus Omeza® Skin Protectant showed significantly faster formation of new tissue in MRSA USA300-infected wounds compared to the silver dressing and the control group.

RS Offers Omron Automation's Advanced Suite of Traceability 4.0 Solutions for Industry 4.0 Applications

Retrieved on: 
Wednesday, December 6, 2023

FORT WORTH, Texas, Dec. 6, 2023 /PRNewswire/ -- RS, a trading brand of RS Group plc (LSE: RS1), a global provider of product and service solutions for industrial customers, offers Omron Automation's advanced suite of Traceability 4.0 solutions for Industry 4.0 applications.

Key Points: 
  • FORT WORTH, Texas, Dec. 6, 2023 /PRNewswire/ -- RS , a trading brand of RS Group plc (LSE: RS1), a global provider of product and service solutions for industrial customers, offers Omron Automation's advanced suite of Traceability 4.0 solutions for Industry 4.0 applications.
  • Traceability 2.0 added inventory and finished goods visibility in the 1980s, and Traceability 3.0 added material and production unit visibility in the 2000s.
  • Omron solutions include machine automation controllers designed to facilitate complete process control, boost system flexibility, and enhance overall traceability performance.
  • For more information about Traceability 4.0, please check out Omron's new "Traceability 4.0 for Industry 4.0" RS Expert Advice article and visit the links embedded here.

New Clinical Data Demonstrate >90 Percent Area Reduction in Diabetic Foot Ulcers within 12 Weeks or less Using Novel Omeza® Platform plus Offloading

Retrieved on: 
Wednesday, December 6, 2023

In the study, patients with DFUs were treated with OCM™, Omeza® Lidocaine Lavage, and Omeza® Skin Protectant.

Key Points: 
  • In the study, patients with DFUs were treated with OCM™, Omeza® Lidocaine Lavage, and Omeza® Skin Protectant.
  • Patients also received standard of care, which included offloading—minimizing weight placed on the foot to help prevent and heal ulcers along with diabetes control.
  • By week twelve, the average PAR was 91 percent, with two additional patients achieving complete closure of their DFUs.
  • Both of these cases were of ≥1 year duration prior to Omeza® combination therapy and standard of care.